Aardvark Therapeutics AARD Growth Metrics (2025-2026)

NASDAQ AARD
$5.35 +0.08 (+1.52%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Aardvark Therapeutics Quarterly Growth Metrics

Periods 5 quarters
Latest Jun 2026

Aardvark Therapeutics growth metrics data for the quarter ended Jun 2026. These growth metrics cover 5 quarters of results from Jun 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Return on Assets [ROA] Growth (1y)ROA Growth (1y) -4122.00-5368.00
Return on Assets [ROA] (QoQ)ROA (QoQ) -43.00-1077.00-1127.00-1877.00-1288.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) -4967.00-5964.00
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) -86.00-1247.00-1345.00-2290.00-1082.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y) -1470.00-6104.00
Return on Equity [ROE] (QoQ)ROE (QoQ) 3,210.00-1223.00-1270.00-2188.00-1424.00

Aardvark Therapeutics Growth Metrics API

Pull Aardvark Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=AARD&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY